Patents by Inventor Yoko Wakabayashi

Yoko Wakabayashi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MARKER ASSOCIATED WITH NON-ALCOHOLIC STEATOHEPATITIS
    Publication number: 20150247869
    Abstract: Disclosed is a novel NASH marker for use in a method for detecting NASH or evaluating the severity of NASH, which utilizes at least one factor selected from the group consisting of an IL-1 receptor antagonist, sCD40, HMGB1, sPLA2 group IIA and an sPLA2 activity as the marker. Also disclosed is a method for detecting NASH or evaluating the severity of NASH in a subject, which utilizes the marker.
    Type: Application
    Filed: May 18, 2015
    Publication date: September 3, 2015
    Applicant: Mochida Pharmaceutical Co., Ltd.
    Inventors: Ayumi SATO, Tsuyoshi HARADA, Takashi YANO, Yoko WAKABAYASHI
  • Marker associated with non-alcoholic steatohepatitis
    Patent number: 9060981
    Abstract: Disclosed is a novel NASH marker for use in a method for detecting NASH or evaluating the severity of NASH, which utilizes at least one factor selected from the group consisting of an IL-1 receptor antagonist, sCD40, HMGB1, sPLA2 group IIA and an sPLA2 activity as the marker. Also disclosed is a method for detecting NASH or evaluating the severity of NASH in a subject, which utilizes the marker.
    Type: Grant
    Filed: October 15, 2010
    Date of Patent: June 23, 2015
    Assignee: MOCHIDA PHARMACEUTICAL CO., LTD.
    Inventors: Ayumi Sato, Tsuyoshi Harada, Takashi Yano, Yoko Wakabayashi
  • MARKER ASSOCIATED WITH NON-ALCOHOLIC STEATOHEPATITIS
    Publication number: 20120231471
    Abstract: Disclosed is a novel NASH marker for use in a method for detecting NASH or evaluating the severity of NASH, which utilizes at least one factor selected from the group consisting of an IL-1 receptor antagonist, sCD40, HMGB1, sPLA2 group IIA and an sPLA2 activity as the marker. Also disclosed is a method for detecting NASH or evaluating the severity of NASH in a subject, which utilizes the marker.
    Type: Application
    Filed: October 15, 2010
    Publication date: September 13, 2012
    Inventors: Ayumi Sato, Tsuyoshi Harada, Takashi Yano, Yoko Wakabayashi